Fig. 1From: Field safety and efficacy of an orally administered combination of sarolaner, moxidectin and pyrantel (Simparica Trio®) for the prevention of angiostrongylosis in dogs presented as veterinary patientsLocations of the study sites in Denmark (red markers) and Italy (blue markers)Back to article page